Background The aim of this study was to evaluate the association between red blood cell (RBC) transfusions on the risk of death, retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD), and necrotizing enterocolitis (NEC) in very low birth weight (VLBW) infants. Study Design and Methods This is an observational study. Data were entered prospectively into the study database at the time of the first transfusion. Clinical characteristics, adverse events, and outcomes of the patients transfused in the first 28 days of life were compared with the population of VLBW infants not transfused during the same period. The association among birth weight, gestational age, comorbidities, and the number of transfusions was estimated with a Poisson regression model. The association between the composite outcome and the occurrence of death, ROP, or BPD separately considered and a set of covariates was estimated with a logistic regression model. Results We enrolled 641 VLBW infants, 42% of whom were transfused. Transfusions were associated with the risk of developing the composite outcome, independently from other conditions; this risk correlated with several transfusions ! 3 (odds ratio: 5.88, 95% confidence interval: 2.74-12.6). ROP and BPD were associated with several transfusions ! 3. Conclusion We observed an association between RBC transfusions and the composite risk of death or ROP, BPD, and NEC.
Red blood cell (RBC) transfusion is an important supportive therapy in the neonatal period. Nearly 40% of preterm newborns with birth weight (BW) between 1,000 and 1,500 g (very low BW [VLBW] ) and more than 90% weighing less than 1,000 g (extremely low BW [ELBW] ) receive at least one blood transfusion during their hospital stay. [1] [2] [3] [4] The most common rationale for transfusing packed RBC in preterm infants is to improve oxygen delivery. Many neonatal intensive care units (NICUs) adopt transfusion guidelines based on hemoglobin or hematocrit levels combined with clinical conditions, days of life, and the need for respiratory or oxygen supports. However, no biochemical or instrumental tests have identified a target hemoglobin or hematocrit below which an RBC transfusion can definitely provide benefits to premature newborns.
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Furthermore, there is a growing body of evidences that RBC transfusions could be harmful. Studies in adult and pediatric patients found a significant association between RBC transfusion and increased mortality or morbidity. [14] [15] [16] [17] [18] [19] In the past few years, evidence for a negative effect of RBC transfusions was also reported in neonatal clinical practices. dos Santos et al observed that RBC transfusions in VLBW infants were associated with higher risk of death 20 and many observational studies suggest a temporal relationship between RBC transfusion and the development of necrotizing enterocolitis (NEC) and germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH) in VLBW infants. [21] [22] [23] [24] [25] [26] [27] [28] [29] Various hypotheses have been advocated for these associations, but none of them has yet been confirmed. The introduction of gamma irradiation and leukocyte reduction from RBC before storage was demonstrated to reduce the incidence of retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD) in newborns weighing less than 1,250 g. 30 The use of RBC units with a short period of storage has been associated with lower morbidity and mortality in adult and pediatric patients, 31-33 but these advantages were not confirmed in premature newborns. 34 The cause-and-effect relationship of RBC transfusion with adverse clinical outcomes is difficult to establish due to numerous multiple confounding factors. Two randomized trials 2,12 did not find differences in death, ROP, BPD, or NEC between patients transfused with different transfusion threshold; various observational trials in premature and VLBW infants [14] [15] [16] [17] [18] [19] [34] [35] [36] suggested a worsening of short-and longterm prognoses in the most transfused infants, but definitive conclusions have yet to be drawn. Our study investigates the hypothesis that RBC transfusions are associated with an increased risk of death or the development of NEC, ROP, and BPD in a large cohort of VLBW infants.
Materials and Methods
Inclusion criteria: This single-center longitudinal study enrolled all infants with BW 1,500 g born between January 2007 and December 2012 at our institution or outborn admitted to our NICU within 6 hours of life. Exclusion criteria: Infants with major congenital anomalies, chromosomal defects, metabolic diseases, congenital heart disease, born from human immunodeficiency virus-positive mothers, and dead in the first 24 hours of life were excluded.
Data Collection and Definitions
Neonates included in the study underwent transfusion according to our institutional transfusion guidelines in force since 2006 and unchanged during the study period (►Table 1). Data collected from electronic medical records were entered prospectively into the study database at the time of the first transfusion and updated after every RBC transfusion. Data of not transfused VLBW admitted to our NICU during the same time lapse were collected retrospectively at the end of each year. Clinical characteristics, adverse events, and outcomes of the VLBW infants transfused in the first 28 days of life were compared with the population of VLBW not transfused during the same time lapse. We analyzed the following neonatal characteristics: gestational age (GA); BW; Apgar score at 1 and 5 minutes of life; small for GA (SGA) defined as a BW < 10th percentile for GA, need for intubation in the delivery room, twins and multiples, days of mechanical ventilation (when more than 5 days), pharmaco- 
Statistical Analysis
Differences and 95% confidence interval (CI) in the conditions at birth, morbidity, and outcome within the 28th day of life between not transfused and transfused neonates were computed with Pearson chi-square test and Fisher exact test in the whole group of newborns enrolled and in the ELBW subgroup. To investigate the role of transfusions in the development of the outcomes considered, independently from illness severity, we introduced a dichotomous variable (comorbidities) which included sepsis, IVH 3 and 4 degrees grade, mechanical ventilation > 5 days, intubation in the delivery room, and major surgery in the first 14 days. The association among BW, GA, the presence of at least one comorbidity, and the number of transfusions performed within the 28th day of life was estimated with a multivariable Poisson regression model for both transfused and not transfused infants. Results were expressed as mean and 95% CI. The association between the composite outcome (death, ROP, BPD, or NEC) and a set of covariates was estimated with a logistic regression model. The set included BW, GA, comorbidities (model 1), and number of transfusions (model 2). The results were expressed as odds ratios (OR) and 95% CI. An analogous model was used to estimate the association between the occurrence of death, ROP, or BPD separately considered and the above covariates. NEC was not considered since it occurred in 15 cases only.
Results
During the study period, 765 VLBW infants were admitted to our NICU; 124 were excluded because they did not meet the inclusion criteria. Patients enrolled in the study were 641, 241 of whom (37.6%) were ELBW infants. Mean GA was 29. 
Discussion
We observed an association between RBC transfusions in the first 28 days of life and the risk of developing the composite outcome of death, ROP, BPD, or NEC in a cohort of VLBW infants; transfusions were also associated with ROP grade ! 2 and BPD, separately analyzed. We performed a control for gestational age, BW, and illness severity (i.e., sepsis, GMH-IVH grade ! 3, mechanical ventilation for at least 5 days, major surgery, and intubation in the delivery room), as these conditions are associated with higher transfusion needs, and, at the same time, are main determinants for the outcomes considered. Our data showed a correlation between outcomes and the number of transfusions performed, independently from other variables, and weighted the effect of transfusions in the development of the outcomes considered. The association between RBC transfusion and increased mortality rate was described by dos Santos et al in a cohort of more than 1,000 VLBW infants; they reported a 1.49 times higher risk of death in patients transfused in the first month of life compared with infants who were not, and the risk increased for those infants transfused more than twice in the period considered. 25 Our study did not confirm this association; this could be due to the difference in mortality rates between the two cohorts (9 vs. 27.8%). Another difference between the two studies is related to transfusion practices: our patients were transfused according to the same institutional guidelines, where in the multicenter trial Abbreviations: BPD, bronchopulmonary dysplasia; CI, confidence interval; GMH-IVH, germinal matrix hemorrhage-intraventricular hemorrhage; NEC, necrotizing enterocolitis; PDA, patent ductus arteriosus; ROP, retinopathy of prematurity; SGA, small for gestational age. Note: 95% confidence interval for percentage differences "not transfused versus transfused". Statistically significant differences are in bold. chronic anemia with a mechanism of hypoperfusion and reperfusion, (2) enteral nutrition that could reduce mesenteric blood flow during RBC transfusion, (3) exposure to biologically active mediators accumulated during storage, and (4) impaired gut microcirculation and tissue hypoxia secondary to prolonged storage that increases RBC adhesion and depletes erythrocyte nitric oxide. However, none of these hypotheses has been definitively confirmed. The present study did not confirm this association and two recent reports showed similar results 39, 40 ; the lack of association between Abbreviations: BPD, bronchopulmonary dysplasia; BW, birth weight; CI, confidence interval; GA, gestational age; ROP, retinopathy of prematurity. Note: Statistically significant differences are in bold.
NEC and RBC transfusions in our patients could be related to the very low incidence of NEC, compared with other studies. Two recent meta-analysis of observational and randomized trials have come to different conclusions; the pooled results from randomized trials supported a correlation between low RBC transfusion rate and the development of NEC, 41 but no time correlations between transfusion and the development of NEC were possible. These results contrasted with those drawn from the meta-analysis of observational studies by Mohamed and Shah et al 24 that confirmed the temporal correlation between the two events. Recently, a multicenter, randomized trial 34 showed no statistical differences for the composite risk of NEC, ROP, BPD, GMH-IVH, and death in newborns with BW 1,250 g randomized to be transfused with RBC units stored for a mean time of 5.1 days versus standard issue RBCs (14.6 days), thus excluding a possible role for standard storage time in the development of complications of prematurity. GMH-IVH has been recently associated with early RBC transfusions in neonatal life. 28, 29 Reactive oxygen species, endothelial activation, capillary slugging in the germinal matrix, and increased capillary pressure due to mechanical or biochemical properties of banked RBC have been advocated as possible mechanisms of transfusion-related GMH-IVH. 19 In our study, all ELBW newborns who developed severe IVH were transfused in the first month of life, but we were not able to investigate a temporal association between the two events. Delayed cord clamping and umbilical cord milking are well-known procedures to augment circulating RBC and hemoglobin. Both are associated with a reduction in the incidence of IVH and NEC. [42] [43] [44] According to these observations, that some cases of IVH and NEC are preceded by a RBC transfusion, one possible mechanism to explain the benefits derived from placental transfusion is the reduction in transfusion needs in the first week of life. Recently, a possible role for anemia and RBC transfusion in the development of ROP has been reported although evidences are contrasting. 12, 45, 46 Blood transfusions are supposed to increase the risk of ROP by augmenting retinal oxygen levels; another pathophysiological mechanism attributed to RBC transfusion is free iron overload that could contribute to the production of free oxygen radicals directly responsible for the damage to the developing retinal vessels. Theoretically, allogeneic umbilical RBC transfusions may play a protective role in the development of complications associated with oxidative damages, particularly in the most premature infants. This intriguing hypothesis should be tested in future randomized trials. The main limitation of this study is the introduction of a selection bias related to the fact that patients transfused are sicker and the outcomes considered are strongly related to comorbidities; thus, transfusions could be only a marker for illness severity. However, the variables related to illness severity were adjusted by using the most significant clinical variables associated with increased transfusion needs, morbidity, and mortality. The logistic regression model showed that RBC transfusion contributed to the development of the adverse outcomes considered independently from clinical conditions. It is important to point out that, although significant, the contribution of transfusions to the development of complications of prematurity was smaller, compared with GA, BW, and the presence of comorbidities. In the past years, two randomized trials 2,12 that investigated different transfusion thresholds did not find significant associations between number of transfusions and the development of death, ROP, BPD, and NEC. The study by Bell et al 12 was designed to assess primarily the differences in transfusion needs between two transfusion thresholds in 100 newborns with BW less than 1,300 g. Infants in the liberal group received more RBC transfusions compared with the restrictive group; the latter showed a higher rate of periventricular leukomalacia and intraparenchymal hemorrhage and a trend to develop fewer cases of ROP and BPD. The premature infant in need of transfusion (PINT) trial 2 enrolled 451 ELBW infants to two transfusional regimens to investigate differences in the composite outcome of death or ROP, BPD, and NEC. In our opinion, this study did not allow to draw definitive conclusions about the possible correlation between number of transfusions and outcomes because there were no statistical differences in the number of transfusions performed between the two arms of the trial. A recent metaanalysis by Ibrahim et al 35 concluded that a restrictive RBC transfusion threshold resulted in a significant lower number of transfusions and donor exposures and can be used without incurring in clinically important increase in the risk of death or major short-term neonatal morbidities. In their review, Whyte and Kirpalani came to more prudent conclusions suggesting to avoid hemoglobin levels below the lower limits tested, given the uncertainties of the available data; however, they state that a restrictive practice does not appear to have a significant impact on death or major morbidities. Long-term neurodevelopment outcomes from the patients enrolled in the PINT trial showed some weak evidence of benefits from the higher hemoglobin threshold group 52 ; conversely, a statistically significant difference in associative verbal fluency, visual memory, and reading ability, favoring the restrictive threshold arm was reported in a subgroup of patients enrolled in the IOWA study, 53 that was in contrast to the shortterm outcomes from the same group, that showed a lower rate of brain damage. The effects of transfusion thresholds on neurocognitive outcome of ELBW (EETNO) trial is ongoing 54 and will contribute to clarify the long-term effects of transfusions at different hemoglobin threshold in ELBW infants. Our study highlights a significant association between RBC transfusions and short-term outcomes in VLBW infants. There are some plausible biologic explanations for a contribution of RBC transfusions to the development of complications of prematurity. However, it is possible that sicker infants are more likely to be transfused and therefore prone to develop complications. The observational nature of our study could not elucidate the eventual cause-effect relationships and large randomized trials are required to confirm the possible detrimental role of RBC transfusions in premature infants.
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